| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 12/23/2009 | EP2134337A1 Novel burn treatment composition |
| 12/23/2009 | EP1549651B1 Pyrimidopyrimidones as kinase inhibitors |
| 12/23/2009 | EP1296972B1 Arylmethylamine derivatives for use as tryptase inhibitors |
| 12/23/2009 | EP1274726B1 Therapeutic compounds and methods for modulating v3, a versican isoform |
| 12/23/2009 | EP1259487B1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors |
| 12/23/2009 | CN101611050A Pharmaceutically acceptable salts of Thymodepressin and processes for their manufacture |
| 12/23/2009 | CN101611015A Indazolyl ester and amide derivatives for the treatment of glucocorticoid receptor mediated disorders |
| 12/23/2009 | CN101610751A Prophylactic or therapeutic agent for alopecia |
| 12/23/2009 | CN101608155A Kidney-invigorating health-care wine |
| 12/23/2009 | CN101607990A Earthworm active protein, extraction method and application thereof |
| 12/23/2009 | CN101607145A Method for extracting interfacial active sapindoside and organic matter from soapberry fruit and finished product |
| 12/23/2009 | CN101607040A Drug for curing knife and gun injury and traumatic injury ulcerate as well as preparation method thereof |
| 12/23/2009 | CN101607039A External medicinal wine for diminishing inflammation and resolving masses and production method thereof |
| 12/23/2009 | CN101607028A Dermatologic medicine prepared from wartwort plant |
| 12/23/2009 | CN101607020A Medicament for curing urticaria |
| 12/23/2009 | CN101607018A Externally-applied plaster with functions of detoxifying and promoting tissue regeneration |
| 12/23/2009 | CN101607014A Ointment for promoting tissue regeneration and restraining sore and preparation method thereof |
| 12/23/2009 | CN101607004A Separation and concentration method of drug extract liquid for preparing inflammation-diminishing and defervescing preparation |
| 12/23/2009 | CN101606988A Anti-loss and hair-growing preparation of six ingredients, preparation method and quality testing method thereof |
| 12/23/2009 | CN101606959A Acupoint implanted drug for treating psoriasis |
| 12/23/2009 | CN101606958A Burn and scald ointment |
| 12/23/2009 | CN101606954A Method for extracting and purifying flavonoid substance from selaginella tamariscina |
| 12/23/2009 | CN101606938A Compound medicine for treating skin desquamation of sweaty hands |
| 12/23/2009 | CN101606929A Application of deoxypodophyllotoxin |
| 12/23/2009 | CN101606899A Traditional Chinese medicine freckle whitening makeup |
| 12/23/2009 | CN101606698A Natural colour viscera-nourishing nutritional noodles and preparation method |
| 12/23/2009 | CN101606692A Natural colour viscera-nourishing nutritional porridge and preparation method |
| 12/23/2009 | CN100571773C Method and composition for treating skin wounds with epidermal growth factor |
| 12/23/2009 | CN100571771C Use of repeated sequence protein polymers in personal care compositions |
| 12/23/2009 | CN100571765C Chinese-medicinal decoction for treating hives |
| 12/23/2009 | CN100571744C Chinese-medicinal decoction for treating hives |
| 12/23/2009 | CN100571738C Externally used salves for treating burn with double formulations and preparation method thereof |
| 12/23/2009 | CN100571713C Novel use of silver peroxide |
| 12/23/2009 | CN100571706C Preparation method of externally applied Chinese medicinal tincture for treating psoriasis |
| 12/23/2009 | CN100571705C Powder for treating scald |
| 12/23/2009 | CN100571677C Eucalyptus extracts |
| 12/23/2009 | CA2728664A1 Dermatological pharmaceutical composition for the treatment of skin inflammation diseases, such as dermatitis, atopic dermatitis, vitiligo, alopecia areata, acne, psoriasis, pruritus or combinations of them |
| 12/23/2009 | CA2728155A1 Combination of a tiliroside and a peptide |
| 12/23/2009 | CA2727154A1 Oxybuprocaine-containing analgesic/antipruritic external preparation |
| 12/22/2009 | US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide |
| 12/22/2009 | US7635774 Benzimidazole derivatives |
| 12/22/2009 | US7635681 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 12/22/2009 | US7635674 insulin and carrieres, a second pharmaceutical composition containing O-(3-piperidino-2-hydroxy-1-propyl)nicotinic amidoxime ( BGP-15) and carriers; prediabetic state, metabolic X-syndrome, insulin sensitivity, glucose tolerance, dislipidemia or diabetes mellitus |
| 12/22/2009 | US7635592 Generating tissue solid support; obtain matrix intensifying particles, couple to solid support, incubate with cell and growth factor, propagate tissue |
| 12/22/2009 | US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 12/22/2009 | CA2627862C Use of inhibitors of dipeptidyl peptidase iv (dp iv) in combination with inhibitors of alanyl-aminopeptidase (apn) |
| 12/22/2009 | CA2482447C Dual dispenser for aesthetically acceptable delivery of anhydrous skin treatment compositions |
| 12/22/2009 | CA2470639C Preparation for wound healing and prevention of bandage adhesion to the wound |
| 12/22/2009 | CA2452558C A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
| 12/22/2009 | CA2416527C Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 12/22/2009 | CA2415214C Phosphotetrahydropyran compounds |
| 12/22/2009 | CA2413026C Cold water soluble .beta.-glucan product and process for preparing the same |
| 12/22/2009 | CA2405593C Macrolides |
| 12/22/2009 | CA2402421C Clathrate complexes formed by hyaluronic acid derivatives and use thereof as pharmaceuticals |
| 12/22/2009 | CA2347752C N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 12/22/2009 | CA2307879C Treatment of t-helper cell type 2 mediated immune diseases |
| 12/20/2009 | CA2637538A1 Dar 1 (dermal acne remover) |
| 12/17/2009 | WO2009152493A2 Use of apolipoproteins to decrease inflammation |
| 12/17/2009 | WO2009152374A2 Method for treating chronic wounds |
| 12/17/2009 | WO2009152372A1 Control of blood vessel physiology to treat skin disorders |
| 12/17/2009 | WO2009151828A1 Health and cosmetic composition and regime for stimulating hair growth and thickening on the head, including the scalp, eyelashes, and eyebrows, and which discourages hair loss |
| 12/17/2009 | WO2009151626A1 Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists |
| 12/17/2009 | WO2009151621A1 Substituted (1, 2, 4-0xadiaz0l-3-yl) indolin-1-yl carboxylic acid derivatives useful as s1p1 agonists |
| 12/17/2009 | WO2009151330A1 Nutritional composition for infants delivered via caesarean section |
| 12/17/2009 | WO2009151315A1 Nutritional composition for infants delivered via caesarean section |
| 12/17/2009 | WO2009151212A2 External preparation composition for skin comprising ginseng flower or ginseng seed extracts |
| 12/17/2009 | WO2009151057A1 Process for production of antioxidant active substance |
| 12/17/2009 | WO2009150902A1 Composition for external use |
| 12/17/2009 | WO2009150310A1 Use of the pat nonapeptide in the treatment of autoimmune diseases |
| 12/17/2009 | WO2009150214A2 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 12/17/2009 | WO2009132093A3 Substituted arylcyclopentenes as therapeutic agents |
| 12/17/2009 | WO2009108762A3 Methods and compositions for treatment of retinoid-responsive conditions |
| 12/17/2009 | US20090312543 Pyrazole compounds useful as protein kinase inhibitors |
| 12/17/2009 | US20090312390 Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 12/17/2009 | US20090312334 Immunomodulating Heterocyclic Compounds |
| 12/17/2009 | US20090312322 Use of Oxindole Derivatives in the Treatment of Dementia Related Diseases, Alzheimer's Disease and Conditions Associated with Glycogen Synthase Kinase-3 |
| 12/17/2009 | US20090312313 Compound having tgfbeta inhibitory activity and pharmaceutical composition comprising the same |
| 12/17/2009 | US20090312296 Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseases |
| 12/17/2009 | US20090312283 Branched hyaluronic acid and method of manufacture |
| 12/17/2009 | US20090311792 Fibroblast growth factor (FGF23) and methods for use |
| 12/17/2009 | US20090311348 Pharmeceutical and cosmetic use of silica |
| 12/17/2009 | US20090311346 Method for treating acne |
| 12/17/2009 | US20090311313 Methods for treating tweak-related conditions |
| 12/17/2009 | US20090311309 Novel Tissue Support |
| 12/17/2009 | US20090311308 Skincare compositions comprising salicyclic acid |
| 12/17/2009 | US20090311307 Hydractive Recipe |
| 12/17/2009 | US20090311296 Active Agent Delivery and/or Odor Retentive Composition and Methods of Use Thereof |
| 12/17/2009 | US20090311292 Process for synthesis and incorporation of nitric oxide donors in macromolecular compositions |
| 12/17/2009 | US20090311215 Method for treating cervical cancer |
| 12/17/2009 | US20090311213 Methods and compositions for treatment of retinoid-responsive conditions |
| 12/17/2009 | DE102008002410A1 Enzymatische Synthese von Sphingolipiden Enzymatic synthesis of sphingolipids |
| 12/17/2009 | DE102008002409A1 Enzymatische Synthese von Sphingolipiden Enzymatic synthesis of sphingolipids |
| 12/17/2009 | CA2727710A1 Control of blood vessel physiology to treat skin disorders |
| 12/17/2009 | CA2727432A1 Method for treating chronic wounds with an extracellular polymeric substance solvating system |
| 12/17/2009 | CA2727272A1 Composition for external use |
| 12/17/2009 | CA2723270A1 Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease |
| 12/16/2009 | EP2133353A1 Novel adenine compound |
| 12/16/2009 | EP2133339A1 Novel (2-aminophenyl)pyridinecarboxamide derivative having urea structure |
| 12/16/2009 | EP2133085A1 Method for creating a protein hydrolysate without antigens from the feet of immunologically immature poultry |
| 12/16/2009 | EP2133083A1 Therapeutic agent for infectious skin or mucosal disease |